| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-04-05 | BlackRock Inc. | Legend Biotech Corp | 10,768,060 | 3.0% | EDGAR |
| SC 13G/A | 2024-02-14 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Legend Biotech Corp | 13,052,732 | 3.6% | EDGAR |
| SC 13G/A | 2024-02-14 | GenScript Biotech Corp | Legend Biotech Corp | 174,497,556 | 48.0% | EDGAR |
| SC 13G | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Legend Biotech Corp | 10,808,216 | 5.9% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Legend Biotech Corp | 25,595,988 | 7.0% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | Legend Biotech Corp | 10,532,376 | 5.8% | EDGAR |
| SC 13G/A | 2023-05-10 | FMR LLC | Legend Biotech Corp | 33,013,448 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Legend Biotech Corp | 20,273,234 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-14 | GenScript Biotech Corp | Legend Biotech Corp | 174,497,556 | 52.1% | EDGAR |
| SC 13G/A | 2023-02-14 | AquaPoint L.P. | Legend Biotech Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Zhang Fangliang | Legend Biotech Corp | 1,067,386 | 0.3% | EDGAR |
| SC 13G | 2023-02-09 | FMR LLC | Legend Biotech Corp | 30,283,156 | 9.2% | EDGAR |
| SC 13G/A | 2022-03-11 | GenScript Biotech Corp | Legend Biotech Corp | 174,497,556 | 57.1% | EDGAR |
| SC 13G/A | 2022-02-14 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Legend Biotech Corp | 33,609,850 | 10.6% | EDGAR |
| SC 13G | 2021-07-12 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Legend Biotech Corp | 30,809,850 | 10.3% | EDGAR |
| SC 13G | 2021-02-16 | GenScript Biotech Corp | Legend Biotech Corp | 169,997,556 | 64.3% | EDGAR |
| SC 13G | 2021-02-16 | AquaPoint L.P. | Legend Biotech Corp | 30,320,000 | 11.5% | EDGAR |
| SC 13G | 2021-02-16 | Zhang Fangliang | Legend Biotech Corp | 32,274,604 | 12.2% | EDGAR |